(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione

C31H36N8O5S — CID 137343796

IUPAC(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
SMILESCC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCn2cccn2)CCNC(=O)c2csc1n2
InChIInChI=1S/C31H36N8O5S/c1-20(2)15-23-31-37-25(19-45-31)28(42)32-11-14-38(27(41)9-13-39-12-6-10-33-39)17-26(40)34-22(16-21-7-4-3-5-8-21)30-36-24(18-44-30)29(43)35-23/h3-8,10,12,18-20,22-23H,9,11,13-17H2,1-2H3,(H,32,42)(H,34,40)(H,35,43)/t22-,23-/m0/s1
InChIKeyMQHJSOHMGLWWOS-GOTSBHOMSA-N
MW632.75 g/mol
LogP2.91
Rot. Bonds7

About (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione

(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione (PubChem CID 137343796) has the molecular formula C31H36N8O5S and a molecular weight of 632.75 g/mol. Its IUPAC name is (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione.

Molecular Properties

Compound Name(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
PubChem CID137343796
Molecular FormulaC31H36N8O5S
Molecular Weight632.75 g/mol
Exact Mass632.25
IUPAC Name(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione
SMILESCC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCn2cccn2)CCNC(=O)c2csc1n2
InChIInChI=1S/C31H36N8O5S/c1-20(2)15-23-31-37-25(19-45-31)28(42)32-11-14-38(27(41)9-13-39-12-6-10-33-39)17-26(40)34-22(16-21-7-4-3-5-8-21)30-36-24(18-44-30)29(43)35-23/h3-8,10,12,18-20,22-23H,9,11,13-17H2,1-2H3,(H,32,42)(H,34,40)(H,35,43)/t22-,23-/m0/s1
InChIKeyMQHJSOHMGLWWOS-GOTSBHOMSA-N
XLogP2.91
TPSA164.35 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500632.75
LogP ≤ 52.91
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Analyze (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The IUPAC name of (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione (CID 137343796) is (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione.
What is the SMILES notation for (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The canonical SMILES for (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione is CC(C)C[C@@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)CN(C(=O)CCn2cccn2)CCNC(=O)c2csc1n2.
What is the InChIKey of (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
The InChIKey is MQHJSOHMGLWWOS-GOTSBHOMSA-N. The full InChI is InChI=1S/C31H36N8O5S/c1-20(2)15-23-31-37-25(19-45-31)28(42)32-11-14-38(27(41)9-13-39-12-6-10-33-39)17-26(40)34-22(16-21-7-4-3-5-8-21)30-36-24(18-44-30)29(43)35-23/h3-8,10,12,18-20,22-23H,9,11,13-17H2,1-2H3,(H,32,42)(H,34,40)(H,35,43)/t22-,23-/m0/s1.
What are the key properties of (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione?
(4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione has a molecular weight of 632.75 g/mol, XLogP of 2.91, 7 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (4S,17S)-17-benzyl-4-(2-methylpropyl)-13-(3-pyrazol-1-ylpropanoyl)-19-oxa-6-thia-3,10,13,16,21,22-hexazatricyclo[16.2.1.15,8]docosa-1(20),5(22),7,18(21)-tetraene-2,9,15-trione is sourced from PubChem (CID 137343796), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).